{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:03:33Z","timestamp":1793343813602,"version":"4.5.0"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,10,15]]},"DOI":"10.2169\/internalmedicine.0944-18","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T22:30:29Z","timestamp":1526596229000},"page":"3029-3033","source":"Crossref","is-referenced-by-count":8,"title":["Propylthiouracil-induced Otitis Media with Antineutrophil Cytoplasmic Antibody-associated Vasculitis"],"prefix":"10.2169","volume":"57","author":[{"given":"Rika","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Shimojima","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Moteki","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Kishida","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65: 1-11, 2013.","DOI":"10.1002\/art.37715"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Jennette JC, Falk RJ. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10: 463-473, 2014.","DOI":"10.1038\/nrrheum.2014.103"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sada KE, Yamamura M, Harigai M, et al. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 16: R101, 2014.","DOI":"10.1186\/ar4550"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sugiyama K, Sada KE, Kurosawa M, Wada J, Makino H. Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan. Clin Exp Nephrol 17: 51-58, 2013.","DOI":"10.1007\/s10157-012-0651-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mouthon L, Dunogue B, Guillevin L. Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). J Autoimmun 48-49: 99-103, 2014.","DOI":"10.1016\/j.jaut.2014.01.018"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wierzbicka M, Szyfter W, Puszczewicz M, Borucki L, Bartochowska A. Otologic symptoms as initial manifestation of Wegener granulomatosis: diagnostic dilemma. Otol Neurotol 32: 996-1000, 2011.","DOI":"10.1097\/MAO.0b013e31822558fd"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yoshida N, Iino Y. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis. Allergol Int 63: 523-532, 2014.","DOI":"10.2332\/allergolint.14-RAI-0774"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Harabuchi Y, Kishibe K, Komabayashi Y. Clinical manifestations of granulomatosis with polyangiitis (Wegener&apos;s granulomatosis) in the upper respiratory tract seen by otolaryngologists in Japan. Clin Exp Nephrol 17: 663-666, 2013.","DOI":"10.1007\/s10157-012-0768-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Harabuchi Y, Kishibe K, Tateyama K, et al. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): a retrospective analysis of 235 patients from a nationwide survey in Japan. Mod Rheumatol 27: 87-94, 2017.","DOI":"10.1080\/14397595.2016.1177926"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Harabuchi Y, Kishibe K. Otitis media with ANCA-associated vasculitis. Practica oto-Rhino-Laryngologica 107: 587-598, 2014.","DOI":"10.5631\/jibirin.107.587"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves&apos; disease. Thyroid 10: 595-599, 2000.","DOI":"10.1089\/10507250050137707"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves&apos; disease treated with propylthiouracil and thiamazole. Endocr J 49: 329-334, 2002.","DOI":"10.1507\/endocrj.49.329"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Takagi D, Nakamaru Y, Maguchi S, Furuta Y, Fukuda S. Otologic manifestations of Wegener&apos;s granulomatosis. Laryngoscope 112: 1684-1690, 2002.","DOI":"10.1097\/00005537-200209000-00029"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66: 222-227, 2007.","DOI":"10.1136\/ard.2006.054593"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Maguchi S, Fukuda S, Chida E, Terayama Y. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated sensorineural hearing loss. Auris Nasus Larynx 28 (Suppl): S103-S106, 2001.","DOI":"10.1016\/S0385-8146(00)00103-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Thamprajamchit S, Jariengprasert C, Rajatanavin R. Propylthiouracil-induced sensorineural hearing loss associated with antineutrophil cytoplasmic antibodies. Endocr Pract 10: 432-437, 2004.","DOI":"10.4158\/EP.10.5.432"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sano M, Kitahara N, Kunikata R. Progressive bilateral sensorineural hearing loss induced by an antithyroid drug. ORL J Otorhinolaryngol Relat Spec 66: 281-285, 2004.","DOI":"10.1159\/000081126"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 43: 405-413, 2000.","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Haroon M, Devlin J. A Case of ANCA-associated systemic vasculitis induced by atorvastatin. Clin Rheumatol 27(Suppl 2): S75-S77, 2008.","DOI":"10.1007\/s10067-008-1020-z"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Yang J, Yao LP, Dong MJ, et al. Clinical characteristics and outcomes of propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis in patients with Graves&apos; disease: a median 38-month retrospective cohort study from a single institution in China. Thyroid 27: 1469-1474, 2017.","DOI":"10.1089\/thy.2017.0468"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ishii R, Imaizumi M, Ide A, et al. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil. Endocr J 57: 73-79, 2010.","DOI":"10.1507\/endocrj.K09E-230"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic anca vasculitides. Arthritis Res Ther 7: R1072-R1081, 2005.","DOI":"10.1186\/ar1789"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mori A, Hira K, Hatano T, et al. Bilateral facial nerve palsy due to otitis media associated with myeloperoxidase-antineutrophil cytoplasmic antibody. Am J Med Sci 346: 240-243, 2013.","DOI":"10.1097\/MAJ.0b013e318288371f"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener&apos;s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 33: 4-9, 1993.","DOI":"10.1002\/ana.410330103"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nakazawa D, Tomaru U, Suzuki A, et al. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 64: 3779-3787, 2012.","DOI":"10.1002\/art.34619"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wang C, Gou SJ, Xu PC, Zhao MH, Chen M. Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Res Ther 15: R196, 2013.","DOI":"10.1186\/ar4386"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ntatsaki E, Carruthers D, Chakravarty K, et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford) 53: 2306-2309, 2014.","DOI":"10.1093\/rheumatology\/ket445"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/20\/57_0944-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T05:21:40Z","timestamp":1571376100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/20\/57_0944-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":27,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0944-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]}}}